SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,356,000 | -26.5% | 11,800 | 0.0% | 0.15% | -42.4% |
| Q3 2014 | $1,844,000 | -31.4% | 11,800 | -45.9% | 0.26% | -29.8% |
| Q2 2014 | $2,689,000 | +26.6% | 21,800 | +6.3% | 0.37% | +10.9% |
| Q1 2014 | $2,124,000 | +162.5% | 20,500 | +127.8% | 0.33% | +32.5% |
| Q4 2013 | $809,000 | – | 9,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zurcher Kantonalbank (Zurich Cantonalbank) | 173,845 | $7,037,000 | 0.28% |
| AMUNDI ASSET MANAGEMENT US, INC. | 537,900 | $21,774,000 | 0.09% |
| NOMURA HOLDINGS INC | 127,903 | $5,175,000 | 0.06% |
| GOLDMAN SACHS GROUP INC | 386,458 | $15,641,000 | 0.01% |
| AQR Capital Management | 26,000 | $1,052,000 | 0.01% |
| GOLDMAN SACHS GROUP INC | 100,000 | $4,047,000 | 0.00% |
| RATIONAL ADVISORS LLC | 288 | $12,000 | 0.00% |
| HSBC HOLDINGS PLC | 5,448 | $220,000 | 0.00% |